Evolving the Use of PRP in Joint Disease: From Injection to Strategy
Danesh Mazloomdoost, MD, medical director at Wellward Medical, explains how platelet-rich plasma therapy has evolved from a single injection into a comprehensive, diagnostics-driven strategy for preserving joint function and delaying surgery.
Danesh Mazloomdoost, MD
April 23, 2026